Zobrazeno 1 - 10
of 198
pro vyhledávání: '"Prajna, NV"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Justin GA, Soleimani M, Zafar S, Cheraqpour K, Green C, Moin M, Prajna NV, Golnik KC, Woreta FA
Publikováno v:
Clinical Ophthalmology, Vol Volume 16, Pp 2041-2046 (2022)
Grant A Justin,1,2 Mohammed Soleimani,3 Sidra Zafar,4 Kasra Cheraqpour,5 Catherine Green,6 Mohammad Moin,7 N Venkatesh Prajna,8 Karl C Golnik,9 Fasika A Woreta4 1Department of Vitreoretinal Surgery, Duke Eye Center, Durham, NC, USA; 2Department of Su
Externí odkaz:
https://doaj.org/article/80ac90f52a9a417eabfef0cadf27de2f
Autor:
Prajna, NV, Radhakrishnan, N, Lalitha, P, Austin, A, Ray, K, Keenan, JD, Porco, T, Lietman, T, Rose-Nussbaumer, J
Publikováno v:
Ophthalmology
OBJECTIVE: To determine if there is a benefit to adjuvant corneal crosslinking (CXL) and to compare natamycin versus amphotericin B for filamentous fungal keratitis. DESIGN: Outcome-masked, 2 × 2 factorial design, randomized controlled clinical tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::397f1092a232a64a2acfc7a5937e97d3
https://europepmc.org/articles/PMC6982573/
https://europepmc.org/articles/PMC6982573/
Autor:
Prajna Nv, Naveen Radhakrishnan
Publikováno v:
Indian Journal of Ophthalmology, Vol 69, Iss 12, Pp 3663-3663 (2021)
Autor:
Naveen Radhakrishnan, Prajna Nv
Publikováno v:
Indian Journal of Ophthalmology
Indian Journal of Ophthalmology, Vol 69, Iss 10, Pp 2565-2565 (2021)
Indian Journal of Ophthalmology, Vol 69, Iss 10, Pp 2565-2565 (2021)
Autor:
Prajna Nv, Sayali Pradhan
Publikováno v:
Delhi Journal of Ophthalmology. 25:267-271
Fluoroquinolone class of an bio cs has become popular by the virtue of its proper es like broad spectrum bactericidal ac vity, be er intraocular concentra on, minimal side eff ects and resistance. Over the years serial modifi ca ons in the parent mol
Autor:
Mock, CN, Donkor, P, Gawande, A, Jamison, DT, Kruk, ME, Debas, HT, Adanu, RMK, Adhikari, S, Ahimbisibwe, A, Alkire, BC, Babigumira, JB, Barendregt, JJ, Beard, JH, Bergström, S, Bickler, SW, Chang, D, Charles, A, Cherian, M, Coonan, T, Desalegn, D, De Vries, CR, Dovlo, D, Dutton, RP, English, M, Farmer, D, Feres, M, Gathuya, Z, Gosselin, RA, Higashi, H, Horton, S, Hsia, R, Johansson, KA, Johnson, CT, Johnson, TRB, Joshipura, M, Kassebaum, NJ, Laxminarayan, R, Levin, C, Lofberg, K, Lozo, S, Mabweijano, J, McCord, C, McPake, B, McQueen, K, Meara, JG, Mkandawire, N, Morgan, MA, Bedane, MM, Nandi, A, Niederman, R, Noormahomed, E, Nuevo, FR, Ogunbodede, E, Ohene-Yeboah, M, Olson, Z, Ottaway, A, Ozgediz, D, Pereira, C, Polan, ML, Prajna, NV, Price, RR, Prinja, S, Ravilla, TD, Hicks, ER, Russell, S, Schecter, WP, Sitkin, N, Sleemi, A, Spiegel, D, Shrime, MG, Srinivasan, S, Stergachis, A, Thind, A, Verguet, S, Vincent, JR, Vlassoff, M, Von Schreeb, J, Vos, T, Weiser, TG, Wilson, IH, Zakariah, A
Publikováno v:
Mock, CN; Donkor, P; Gawande, A; Jamison, DT; Kruk, ME; Debas, HT; et al.(2015). Essential surgery: Key messages from Disease Control Priorities, 3rd edition. The Lancet, 385(9983), 2209-2219. doi: 10.1016/S0140-6736(15)60091-5. UCSF: Retrieved from: http://www.escholarship.org/uc/item/6188x3jp
The Lancet, vol 385, iss 9983
The Lancet, vol 385, iss 9983
The World Bank will publish the nine volumes of Disease Control Priorities, 3rd edition, in 2015-16. Volume 1 - Essential Surgery-identifies 44 surgical procedures as essential on the basis that they address substantial needs, are cost eff ective, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::037b548015c20ddf0397a5f24bc5a4ce
http://www.escholarship.org/uc/item/6188x3jp
http://www.escholarship.org/uc/item/6188x3jp
Autor:
Rose-Nussbaumer, J, Prajna, NV, Krishnan, KT, Mascarenhas, J, Rajaraman, R, Srinivasan, M, Raghavan, A, Oldenburg, CE, O'Brien, KS, Ray, KJ, McLeod, SD, Porco, TC, Lietman, TM, Acharya, NR, Keenan, JD, Lalitha, P, Karpagam, R, Rajkumar, M, Sumithra, SR, Sundar, C, Manikandan, P, Shivananda, N, Whitcher, JP, Lee, S, Cevallos, V, Shapiro, BL, Hong, KC, Fisher, M, Aldave, A, Everett, D, Glover, J, Kannan, KA, Kymes, S, Schwab, I, Everett, DF, Zegans, ME, Kidd, CM
Publikováno v:
Rose-Nussbaumer, J; Prajna, NV; Krishnan, KT; Mascarenhas, J; Rajaraman, R; Srinivasan, M; et al.(2015). Vision-related quality-of-life outcomes in the Mycotic Ulcer Treatment Trial I: A randomized clinical trial. JAMA Ophthalmology, 133(6), 642-646. doi: 10.1001/jamaophthalmol.2015.0319. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/4g75v3zk
IMPORTANCE: Given the limitations in health care resources, quality-of-life measures for interventions have gained importance. OBJECTIVE: To determine whether vision-related quality-of-life outcomes were different between the natamycin and voriconazo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::5a448ab8ff006752d21d33a1909a6c8e
http://www.escholarship.org/uc/item/4g75v3zk
http://www.escholarship.org/uc/item/4g75v3zk
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.